Incyte Corp (INCY)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | INCY | AMGN | VRTX | BMY | GILD |
| Company | Incyte Corp | Amgen Inc | Vertex Pharmaceutic | Bristol-Myers Squibb Company | Gilead Sciences Inc |
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | NYSE | NASDAQ |
| Open | 77.15 | 291.50 | 478.56 | 58.16 | 91.71 |
| High | 77.87 | 291.50 | 479.94 | 58.36 | 91.99 |
| Low | 73.25 | 280.05 | 458.10 | 56.42 | 89.16 |
| Last | 77.26 | 281.77 | 460.42 | 56.69 | 89.53 |
| Change | -0.47 | -14.16 | -23.54 | -1.81 | -2.58 |
| % Change | -0.60% | -4.78% | -4.86% | -3.09% | -2.80% |
| Volume | 1,625,352 | 2,292,400 | 1,004,623 | 8,290,014 | 3,740,099 |
| 20-Day Average Volume | 2,052,856 | 2,352,221 | 1,113,020 | 10,868,876 | 6,922,041 |
| Previous Close | 77.73 | 295.93 | 483.96 | 58.50 | 92.11 |
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical |
| Has Options | Yes | Yes | Yes | Yes | Yes |
| Technicals | |||||
| 20-Day Moving Average | 74.32 | 313.82 | 482.88 | 54.93 | 90.75 |
| 20-Day Raw Stochastic | 61.78% | 2.30% | 3.30% | 51.89% | 30.98% |
| 20-Day Relative Strength | 59.97% | 27.68% | 43.20% | 57.77% | 53.49% |
| Weighted Alpha | +46.18 | -2.43 | +22.46 | +19.71 | +26.30 |
| Today's Opinion | 100% Buy | 40% Sell | 16% Buy | 100% Buy | 80% Buy |
| Previous Opinion | 100% Buy | 40% Sell | 72% Buy | 100% Buy | 96% Buy |
| Last Month's Opinion | 100% Buy | 24% Buy | 56% Buy | 88% Buy | 100% Buy |
| Performance | |||||
| 5-Days | |||||
| %Chg | -8.19% since 11/08/24 | -13.56% since 11/08/24 | -10.95% since 11/08/24 | +4.58% since 11/08/24 | -7.09% since 11/08/24 |
| Low | 73.25 on 11/15/24 | 280.05 on 11/15/24 | 458.10 on 11/15/24 | 56.42 on 11/15/24 | 89.28 on 11/15/24 |
| High | 83.54 on 11/11/24 | 327.58 on 11/11/24 | 518.35 on 11/11/24 | 61.08 on 11/11/24 | 98.90 on 11/11/24 |
| 1-Month | |||||
| %Chg | +15.48% since 10/15/24 | -13.51% since 10/15/24 | -4.99% since 10/15/24 | +7.32% since 10/15/24 | +4.54% since 10/15/24 |
| Low | 64.60 on 10/22/24 | 280.05 on 11/15/24 | 458.10 on 11/15/24 | 51.81 on 10/28/24 | 85.60 on 10/22/24 |
| High | 83.95 on 11/08/24 | 328.25 on 11/08/24 | 519.88 on 11/08/24 | 61.08 on 11/11/24 | 98.90 on 11/11/24 |
| 3-Month | |||||
| %Chg | +24.12% since 08/15/24 | -13.59% since 08/15/24 | -2.51% since 08/15/24 | +15.29% since 08/15/24 | +20.69% since 08/15/24 |
| Low | 61.15 on 09/05/24 | 280.05 on 11/15/24 | 447.70 on 10/07/24 | 46.88 on 08/22/24 | 72.89 on 08/16/24 |
| High | 83.95 on 11/08/24 | 339.17 on 09/23/24 | 519.88 on 11/08/24 | 61.08 on 11/11/24 | 98.90 on 11/11/24 |
| 6-Month | |||||
| %Chg | +34.19% since 05/15/24 | -11.87% since 05/15/24 | +5.18% since 05/15/24 | +27.09% since 05/15/24 | +33.89% since 05/15/24 |
| Low | 56.37 on 05/16/24 | 280.05 on 11/15/24 | 432.22 on 05/16/24 | 39.35 on 07/05/24 | 62.07 on 05/31/24 |
| High | 83.95 on 11/08/24 | 346.85 on 07/25/24 | 519.88 on 11/08/24 | 61.08 on 11/11/24 | 98.90 on 11/11/24 |
| Key Statistics | |||||
| Market Capitalization, $K | 14,974,685 | 159,072,144 | 124,633,728 | 118,648,352 | 114,793,560 |
| Shares Outstanding, K | 192,650 | 537,533 | 257,529 | 2,028,177 | 1,246,266 |
| Annual Sales | 3,695,650,000 | 28,190,000,000 | 9,869,200,000 | 45,006,000,000 | 27,116,000,000 |
| Annual Net Income | 597,600,000 | 6,717,000,000 | 3,619,600,000 | 8,025,000,000 | 5,665,000,000 |
| Last Quarter Sales | 1,137,870,000 | 8,503,000,000 | 2,771,900,000 | 11,892,000,000 | 7,545,000,000 |
| Last Quarter Net Income | 106,460,000 | 2,830,000,000 | 1,045,400,000 | 1,211,000,000 | 1,253,000,000 |
| 60-Month Beta | 0.71 | 0.60 | 0.39 | 0.44 | 0.17 |
| Per-Share Information | |||||
| Most Recent Earnings | 1.07 on 10/29/24 | 5.58 on 10/30/24 | 4.38 on 11/04/24 | 1.80 on 10/31/24 | 2.02 on 11/06/24 |
| Latest Earnings Date | 10/29/24 | 10/30/24 | 11/04/24 | 10/31/24 | 11/06/24 |
| Most Recent Dividend | N/A | 2.250 on 11/18/24 | N/A | 0.600 on 10/04/24 | 0.770 on 09/13/24 |
| Next Ex-Dividends Date | N/A | 11/18/24 | N/A | 10/04/24 | 12/13/24 |
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 15.68 | 0.00 | 49.92 | 20.91 |